Definium Therapeutics - 10 Year Stock Price History | DFTX

Historical daily share price chart and data for Definium Therapeutics since 2016 adjusted for splits and dividends. The latest closing stock price for Definium Therapeutics as of February 12, 2026 is 16.23.

The all-time high Definium Therapeutics stock closing price was 70.35 on April 26, 2021.
The Definium Therapeutics 52-week high stock price is 18.70, which is 15.2% above the current share price.
The Definium Therapeutics 52-week low stock price is 4.70, which is 71% below the current share price.
The average Definium Therapeutics stock price for the last 52 weeks is 9.90.

Definium Therapeutics Historical Annual Stock Price Data
Year	Average Stock Price	Year Open	Year High	Year Low	Year Close	Annual % Change
2026	16.0469	13.6400	18.2300	13.5100	16.2300	21.21%
2025	8.9054	7.5400	14.2000	4.8900	13.3900	92.39%
2024	7.0800	3.6200	11.7500	3.5500	6.9600	90.16%
2023	3.4745	2.4900	4.9300	2.4300	3.6600	66.36%
2022	10.5557	22.8000	22.8000	2.1400	2.2000	-89.37%
2021	42.8781	43.6500	70.3500	20.7000	20.7000	-54.75%
2020	9.6517	0.8400	65.5500	0.7500	45.7500	5346.43%
2019	0.7470	0.6600	1.3650	0.0150	0.8400	27.27%
2018	2.0064	5.0700	6.0000	0.3150	0.6600	-85.19%
2017	8.2416	9.3450	18.7500	3.7050	4.4550	-45.90%

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$1.709B	$0.000B
Definium Therapeutics, Inc. is developing therapeutics intended to solve the underlying causes of psychiatric and neurological disorders and offer patients long-term remission rather than transient symptom reduction. Definium Therapeutics Inc., formerly known as Mind Medicine Inc., is based in NEW YORK.

Stock Name	Country	Market Cap	PE Ratio
Chugai Pharmaceutical (CHGCY)	Japan	$97.316B	33.99
Takeda Pharmaceutical (TAK)	Japan	$58.167B	11.43
Zoetis (ZTS)	United States	$56.704B	20.30
BeOne Medicines - (ONC)	Switzerland	$38.521B	204.23
Daiichi Sankyo, - (DSNKY)	Japan	$36.694B	18.27
Sandoz Group AG (SDZNY)	Switzerland	$35.913B	0.00
United Therapeutics (UTHR)	United States	$20.488B	18.03
Shionogi (SGIOY)	Japan	$19.413B	15.01
Merck (MKKGY)	Germany	$19.348B	11.93
Neurocrine Biosciences (NBIX)	United States	$13.704B	29.81
Ionis Pharmaceuticals (IONS)	United States	$13.663B	0.00
IPSEN (IPSEY)	France	$13.565B	0.00
Summit Therapeutics (SMMT)	United States	$11.760B	0.00
Orion OYJ (ORINY)	Finland	$11.502B	32.86
Madrigal Pharmaceuticals (MDGL)	United States	$10.924B	0.00
Eisai (ESAIY)		$9.134B	0.00
Ono Pharmaceutical (OPHLF)	Japan	$7.656B	18.32
Crinetics Pharmaceuticals (CRNX)	United States	$4.864B	0.00
Stevanato Group S.p.A (STVN)	Italy	$4.724B	26.44
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$4.621B	21.94
Hikma Pharmaceuticals Plc (HKMPF)	United Kingdom	$4.591B	0.00
Corcept Therapeutics (CORT)	United States	$4.295B	46.40
Indivior Pharmaceuticals (INDV)	United States	$4.261B	17.39
NewAmsterdam Pharma (NAMS)	Netherlands	$3.883B	0.00
Centessa Pharmaceuticals (CNTA)	United Kingdom	$3.167B	0.00
Catalyst Pharmaceuticals (CPRX)	United States	$2.941B	9.38
Hypermarcas (HYPMY)	Brazil	$2.835B	19.46
Dyne Therapeutics (DYN)	United States	$2.382B	0.00
Guardian Pharmacy Services (GRDN)	United States	$2.190B	42.18
Soleno Therapeutics (SLNO)	United States	$2.151B	0.00
Avadel Pharmaceuticals (AVDL)	Ireland	$2.113B	0.00
Ocular Therapeutix (OCUL)	United States	$1.994B	0.00
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$1.913B	22.67
Harrow (HROW)	United States	$1.802B	110.59
Ardelyx (ARDX)	United States	$1.764B	0.00
Enliven Therapeutics (ELVN)	United States	$1.662B	0.00
Relay Therapeutics (RLAY)	United States	$1.586B	0.00
Amylyx Pharmaceuticals (AMLX)	United States	$1.576B	0.00
Oruka Therapeutics (ORKA)	United States	$1.559B	0.00
BioCryst Pharmaceuticals (BCRX)	United States	$1.441B	85.50
Collegium Pharmaceutical (COLL)	United States	$1.427B	7.06
Nektar Therapeutics (NKTR)	United States	$1.350B	0.00
Evotec AG (EVO)	Germany	$1.236B	0.00
Xeris Biopharma Holdings (XERS)	United States	$1.147B	0.00
Savara (SVRA)	United States	$1.089B	0.00
Cronos Group (CRON)	Canada	$0.992B	0.00
Theravance Biopharma (TBPH)	United States	$0.989B	41.51
ARS Pharmaceuticals (SPRY)	United States	$0.939B	0.00
Aktis Oncology (AKTS)	United States	$0.915B	0.00
Xencor (XNCR)	United States	$0.873B	0.00
Esperion Therapeutics (ESPR)	United States	$0.827B	0.00
KalVista Pharmaceuticals (KALV)	United States	$0.784B	0.00
Ironwood Pharmaceuticals (IRWD)	United States	$0.722B	17.08
Bioventus (BVS)	United States	$0.669B	13.69
Rigel Pharmaceuticals (RIGL)	United States	$0.634B	5.66
ProKidney (PROK)	United States	$0.602B	0.00
4D Molecular Therapeutics (FDMT)	United States	$0.529B	0.00
Altimmune (ALT)	United States	$0.522B	0.00
Lyell Immunopharma (LYEL)	United States	$0.517B	0.00
Lexeo Therapeutics (LXEO)	United States	$0.496B	0.00
Zevra Therapeutics (ZVRA)	United States	$0.477B	0.00
Organogenesis (ORGO)	United States	$0.477B	0.00
Siga Technologies (SIGA)	United States	$0.476B	6.51
Aquestive Therapeutics (AQST)	United States	$0.466B	0.00
Elite Pharmaceuticals (ELTP)	United States	$0.464B	0.00
Nature's Sunshine Products (NATR)	United States	$0.457B	27.23
Akebia Therapeutics (AKBA)	United States	$0.411B	0.00
USANA Health Sciences (USNA)	United States	$0.386B	10.79
Aclaris Therapeutics (ACRS)	United States	$0.367B	0.00
Protara Therapeutics (TARA)	United States	$0.335B	0.00
Cybin (HELP)	Canada	$0.324B	0.00
Aldeyra Therapeutics (ALDX)	United States	$0.320B	0.00
Relmada Therapeutics (RLMD)	United States	$0.293B	0.00
Larimar Therapeutics (LRMR)	United States	$0.276B	0.00
Minerva Neurosciences (NERV)	United States	$0.274B	0.00
Enlivex Therapeutics (ENLV)	Israel	$0.271B	0.00
Journey Medical (DERM)	United States	$0.266B	0.00
Avalo Therapeutics (AVTX)	United States	$0.266B	0.00
OmniAb (OABI)	United States	$0.245B	0.00
Profound Medical (PROF)	Canada	$0.234B	0.00
Achieve Life Sciences (ACHV)	Canada	$0.228B	0.00
Context Therapeutics (CNTX)	United States	$0.224B	0.00
MediWound (MDWD)	Israel	$0.221B	0.00
Heron Therapeutics (HRTX)	United States	$0.215B	0.00
Surrozen (SRZN)	United States	$0.211B	0.00
Silence Therapeutics (SLN)	United Kingdom	$0.205B	0.00
Tonix Pharmaceuticals Holding (TNXP)	United States	$0.193B	0.00
Innate Pharma SA (IPHYF)	France	$0.181B	0.00
AleAnna (ANNA)	United States	$0.178B	0.00
Galectin Therapeutics (GALT)	United States	$0.178B	0.00
Century Therapeutics (IPSC)	United States	$0.156B	0.00
VAXART, INC (VXRT)	United States	$0.138B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.135B	0.00
Unicycive Therapeutics (UNCY)	United States	$0.134B	0.00
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.134B	0.00
Prelude Therapeutics (PRLD)	United States	$0.131B	0.00
Inhibikase Therapeutics (IKT)	United States	$0.129B	0.00
Cardiol Therapeutics (CRDL)	Canada	$0.118B	0.00
Avita Medical (RCEL)	United States	$0.117B	0.00
Korro Bio (KRRO)	United States	$0.116B	0.00
Cassava Sciences (SAVA)	United States	$0.104B	0.00
Vivani Medical (VANI)	United States	$0.098B	0.00
Incannex Healthcare (IXHL)	Australia	$0.097B	0.00
Verrica Pharmaceuticals (VRCA)	United States	$0.091B	0.00
Pyxis Oncology (PYXS)	United States	$0.084B	0.00
Champions Oncology (CSBR)	United States	$0.082B	34.71
Assertio Holdings (ASRT)	United States	$0.077B	0.00
PolyPid (PYPD)	Israel	$0.073B	0.00
HST Global (HSTC)	United States	$0.069B	0.00
Gain Therapeutics (GANX)	United States	$0.067B	0.00
Rafael Holdings (RFL)	United States	$0.062B	0.00
PMV Pharmaceuticals (PMVP)	United States	$0.060B	0.00
Fractyl Health (GUTS)	United States	$0.059B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.058B	48.38
BioNxt Solutions (BNXTF)	Canada	$0.057B	0.00
Dominari Holdings (DOMH)	United States	$0.056B	0.00
Procaps Group, S.A (PROCF)	Luxembourg	$0.056B	0.00
NRx Pharmaceuticals (NRXP)	United States	$0.054B	0.00
Nutriband (NTRB)	United States	$0.052B	0.00
Radnostix (INIS)	United States	$0.051B	0.00
Lipocine (LPCN)	United States	$0.048B	0.00
Acrivon Therapeutics (ACRV)	United States	$0.047B	0.00
ElectroCore (ECOR)	United States	$0.044B	0.00
Lite Strategy (LITS)	United States	$0.039B	0.00
FibroGen (FGEN)	United States	$0.039B	0.00
Telomir Pharmaceuticals (TELO)	United States	$0.039B	0.00
Talphera (TLPH)	United States	$0.038B	0.00
Plus Therapeutics (PSTV)	United States	$0.038B	0.00
Mural Oncology (MURA)	Ireland	$0.035B	0.00
SCYNEXIS (SCYX)	United States	$0.034B	0.00
Reviva Pharmaceuticals Holdings (RVPH)	United States	$0.030B	0.00
Wellgistics Health (WGRX)	United States	$0.028B	0.00
TherapeuticsMD (TXMD)	United States	$0.028B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.024B	0.00
Natural Alternatives (NAII)	United States	$0.021B	0.00
Jupiter Neurosciences (JUNS)	United States	$0.021B	0.00
Citius Pharmaceuticals (CTXR)	United States	$0.019B	0.00
VYNE Therapeutics (VYNE)	United States	$0.019B	0.00
Scienture Holdings (SCNX)	United States	$0.018B	0.00
Klotho Neurosciences (KLTO)	United States	$0.017B	0.00
Liminatus Pharma (LIMN)	United States	$0.016B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.016B	0.00
Vivos Therapeutics (VVOS)	United States	$0.016B	0.00
Traws Pharma (TRAW)	United States	$0.016B	0.02
Cosmos Health (COSM)	United States	$0.015B	0.00
Vyome Holdings (HIND)	United States	$0.014B	0.00
Phio Pharmaceuticals (PHIO)	United States	$0.014B	0.00
Mannatech (MTEX)	United States	$0.014B	0.00
BioLineRx (BLRX)	Israel	$0.013B	0.00
Tempest Therapeutics (TPST)	United States	$0.011B	0.00
Inotiv (NOTV)	United States	$0.011B	0.00
Addex Therapeutics (ADXN)	Switzerland	$0.010B	0.00
CASI Pharmaceuticals (CASI)	China	$0.009B	0.00
TransCode Therapeutics (RNAZ)	United States	$0.009B	0.00
BioVie (BIVI)	United States	$0.009B	0.00
Ainos (AIMD)	United States	$0.008B	0.00
Curanex Pharmaceuticals Inc (CURX)	United States	$0.008B	0.00
XTL Biopharmaceuticals (XTLB)	Israel	$0.008B	0.00
Kiora Pharmaceuticals (KPRX)	United States	$0.008B	0.00
Nuvilex (PMCB)	United States	$0.007B	0.00
Biomerica (BMRA)	United States	$0.007B	0.00
Quoin Pharmaceuticals (QNRX)	United States	$0.007B	0.00
Mangoceuticals (MGRX)	United States	$0.006B	0.00
Alaunos Therapeutics (TCRT)	United States	$0.006B	0.00
Heatwurx (PCSA)	United States	$0.006B	0.00
Aptorum Group (APM)	United Kingdom	$0.005B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.005B	0.00
Salarius Pharmaceuticals (SLRX)	United States	$0.005B	0.00
Redhill Biopharma (RDHL)	Israel	$0.005B	0.00
Xenetic Biosciences (XBIO)	United States	$0.005B	0.00
60 Degrees Pharmaceuticals (SXTP)	United States	$0.004B	0.00
Indaptus Therapeutics (INDP)	United States	$0.004B	0.00
XORTX Therapeutics (XRTX)	Canada	$0.003B	0.00
InMed Pharmaceuticals (INM)	Canada	$0.003B	0.00
Lyra Therapeutics (LYRA)	United States	$0.002B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.002B	0.00
Ernexa Therapeutics (ERNA)	United States	$0.002B	0.00
Jaguar Animal Health (JAGX)	United States	$0.002B	0.00
SciSparc (SPRC)	Israel	$0.002B	0.00
Universe Pharmaceuticals INC (UPC)	China	$0.002B	0.00
Shuttle Pharmaceuticals Holdings (SHPH)	United States	$0.002B	0.00
CDT Equity (CDT)	United States	$0.002B	0.00
Clearmind Medicine (CMND)	Canada	$0.002B	0.00
PainReform (PRFX)	Israel	$0.001B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.001B	0.00
Aditxt (ADTX)	United States	$0.001B	0.00
Emisphere Technologies (EMIS)	United States	$0.000B	0.00
Grifols, S.A (GRFS)	Spain	$0.000B	0.00
4D Pharma (LBPS)	United Kingdom	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00
RVL Pharmaceuticals (RVLP)	United States	$0.000B	0.00